Chronic fatigue syndrome, the immune system and viral infection.
Bansal, A S, Bradley, A S, Bishop, K N et al. · Brain, behavior, and immunity · 2012 · DOI
Quick Summary
This review examines whether immune system problems and viral infections play a role in ME/CFS. Researchers found modest signs of increased inflammation and cytokines (immune signaling molecules) in some patients, along with weakened natural killer cells that normally fight infections. While patients don't have more herpes virus exposure than healthy people, some evidence suggests their bodies struggle to fully control and clear these viruses, which could explain why symptoms persist.
Why It Matters
Understanding the immune and viral mechanisms in ME/CFS could guide development of targeted therapies more effective than current approaches. This review highlights that viral persistence and immune dysfunction may be interconnected, offering a biological rationale for investigating antivirals, immunomodulatory treatments, and T cell memory restoration.
Observed Findings
Slightly elevated inflammatory parameters and pro-inflammatory cytokines (IL-1, IL-6, TNF-α) are likely present in ME/CFS patients
Impaired natural killer cell function appears evident in the condition
Serology for common herpes viruses does not differ from healthy control populations
Some evidence of viral persistence and inadequate containment of viral replication exists
Herpes viruses may impair T cell memory development, potentially explaining persistent viral replication
Inferred Conclusions
Immune dysfunction in ME/CFS involves both elevated inflammation and impaired viral control mechanisms
Viral persistence may result from herpes virus-induced defects in T cell memory rather than from simple increased exposure
Therapies targeting viral containment and T cell memory restoration may be more effective than current treatment approaches
The heterogeneity of findings suggests ME/CFS may comprise multiple immune and viral phenotypes
Remaining Questions
Which specific immune mechanisms drive viral persistence—is it primarily T cell memory impairment, natural killer cell dysfunction, or both?
What This Study Does Not Prove
This review does not establish causation—whether immune abnormalities cause ME/CFS or result from it remains unclear. It also does not prove that viral persistence is the primary driver in all patients, as ME/CFS is heterogeneous and some cases follow stress rather than infection. The evidence presented is suggestive rather than definitive, reflecting ongoing scientific uncertainty.